Alibaba Group Holding Limited (BABAN)
Mexican Exchange · Mexico · prices in MXN · close of 23 Oct 2026
Key indicators
| Last close | MXN 1,861.33 |
|---|---|
| 52-week range | 1,627.00 – 3,345.99 |
| Return, 1 month / 3 months | −4.3% / −6.4% |
| Return, 1 year / 3 years | −40.6% / +34.2% |
| Trend | Below its 200-day average |
| RSI (14) | 37 |
| Volatility (1 year) | 40.6% |
| Worst drawdown (1 year) | -49.5% |
| Average daily value traded | 10.40M MXN |
| Dividend yield | 1.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Alibaba Group Holding Limited runs online marketplaces where merchants offer goods to consumers and businesses, chiefly through its Taobao and Tmall platforms in China. It also provides cloud computing and digital infrastructure services to enterprises, along with logistics support and marketing services for sellers. The company is based in Hangzhou, China, and serves shoppers, small businesses and large brands across its retail and wholesale networks.
The shares are listed on the Mexican Exchange in Mexico under the code BABAN, and the price on this page is in Mexican pesos (MXN). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Alibaba Group Holding Limited (BABAN) trades on the Mexican Exchange in Mexico. It last closed at MXN 1,861.33 on 23 October 2026.
Its price-based Market X-Ray is 23 out of 100 (a weak price profile), ranking 330 of 361 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 40.6% and over the last three months it fell 6.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Mexican Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 8 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -16.0% | ||
| From 52-week high | -43.9% | ||
| Momentum | 11 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -6.4% | ||
| 6-month return | -18.0% | ||
| 12-month return, skipping the last month | -37.9% | ||
| Stability (higher is calmer) | 17 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 40.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -49.5% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 10.40M MXN | ||
| Zero-volume days | 0.0% | ||
| Income | 17 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.0% | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −7.6% |
|---|---|
| 1 month | −4.3% |
| 3 months | −6.4% |
| 6 months | −18.0% |
| 1 year | −40.6% |
| 3 years | +34.2% |
| 5 years | −45.2% |
Signals
| 50-day / 200-day average | 1,973.96 / 2,215.14 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 49.92 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Jun 2026 | MXN 17.9199 |
| 12 Jun 2025 | MXN 19.4861 |
| 13 Jun 2024 | MXN 30.4515 |
| 20 Dec 2023 | MXN 16.7213 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Mexican Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.